{"id":1267,"date":"2015-06-17T19:56:00","date_gmt":"2015-06-17T19:56:00","guid":{"rendered":"http:\/\/sites.dundee.ac.uk\/ian-gilbert\/?page_id=1267"},"modified":"2019-12-01T10:18:50","modified_gmt":"2019-12-01T10:18:50","slug":"malaria","status":"publish","type":"page","link":"https:\/\/sites.dundee.ac.uk\/ian-gilbert\/malaria\/","title":{"rendered":"Malaria"},"content":{"rendered":"

\"Ian<\/a>Ian Gilbert’s team of researchers have\u00a0 published a paper “A novel multiple-stage antimalarial agent that inhibits protein synthesis<\/a>”\u00a0 in Nature (522 <\/strong>page 315\u2013320; doi:10.1038\/nature14451<\/a>). Malaria is a major problem in many areas of the world and it is estimated that about 200 million cases of malaria every year and over half a million deaths. The properties of compound DDD107498 are particularly exciting as not only does it have potential for treating malaria with a single dose, it may also prevent the spread of malaria from infected people and it has shown potential to prevent people developing malaria in the first place.<\/p>\n

\"\"<\/p>\n

The malaria DDU team has won the\u00a0Medicines for Malaria Venture (MMV) Project of the Year twice. They won the 2014 Project of the Year<\/a> award for the discovery of the compound DDD107498 and the 2018 Project of the Year<\/a> award for their recent work on discovering potential new drugs for malaria.<\/p>\n

 <\/p>\n